UPDATE: Medtronic traces surgical kit possibly contaminated with fatal brain disease

UPDATE: Medtronic confirms sequence of contamination in deadly brain disease infection warning

Medtronic (NYSE:MDT) is working with New England hospitals and government health officials to track the movement of surgical medical equipment involved in several cases of possible patient exposure to Creutzfeldt-Jakob disease, a rare and fatal relative to the more commonly known "mad cow" disease.

This morning a spokesperson confirmed that Medtronic tools were involved in 7 out of the suspected 13 total cases of patient exposure to the deadly brain disease.

"Medtronic was recently notified by Catholic Medical Center in New Hampshire that our surgical instruments had been used on a patient who may have had sporadic CJD at the time of surgery," according to a company statement. "Upon notification that our instruments had been used in this case, we followed procedures to quickly track that specific set of instruments and have confirmed they were used in 7 additional cases."

Medtronic equipment was also confirmed in the 1st documented case at Catholic Medical Center in N.H., in which a patient who underwent a procedure with the rented tools later died. Autopsy reports have yet to confirm whether that patient carried the rare and fatal Creutzfeldt-Jakob disease, health officials said.

After Catholic Medical informed the Minn.-based medical device giant about the in-hospital exposure, the company used its own databases to track the contaminated tools, which had already been used on patients at Cape Cod Hospital. All instruments in question are currently being quarantined, and health officials will fully confirm the Creutzfeldt-Jakob diagnosis when autopsy reports from the deceased patient come in.

An autopsy is 1 of the only ways to confirm Creutzfeldt-Jakob, a rare but deadly disease that attacks the brain. Only 4 known cases of  Creutzfeldt-Jakob contamination from medical instruments have taken place in the last 40 years, none in the U.S.

Hospitals frequently rent medical equipment directly from the manufacturer, and each time the equipment changes hands it goes through a sterilization procedure. By the time the equipment arrived at Cape Cod Hospital it had undergone 4 different sterilization processes, Dr. Donald Guadagnoli, the hospital’s chief medical officer, told The Boston Globe.

Creutzfeldt-Jakob disease disease attacks the brain through protein-like structures called prions, which are more difficult to completely eradicated during standard hospital sterilization.

Health officials said the risk of further infection is very low because of the number of times the equipment has been sterilized, and because exposed patients underwent spine, not brain surgery. In Mass., the low-risk exposure "is limited to 5 Cape Cod Hospital patients who received procedures between June and August using the same device that was used on the New Hampshire patient," a Mass. health department notice said.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply